Breaking Barriers with Digital Health Technologies: Advancing CRS Risk Prediction

Join us for an exciting resource launch event hosted by DATAcc by DiMe, unveiling new tools designed to support the development of digital health technologies (DHTs) for Cytokine Release Syndrome (CRS) risk prediction. CRS is a serious side effect of immunotherapy, and these innovative tools aim to improve safety and access.

What You’ll Discover

• Strategic Tools for CRS Risk Prediction
• Gain insights into a strategic framework to create reliable, scalable tools for predicting CRS risks.
• Improved Clinical Outcomes
• Explore how these tools enhance patient safety and clinical outcomes for individuals undergoing immunotherapy.
• Equitable Access to Therapies
• Learn how DHTs can help expand access to life-saving immunotherapies while addressing safety concerns.

This event highlights the transformative potential of digital health in advancing care for CRS and ensuring equitable, safe access to critical treatments.